Increasing herd immunity with influenza revaccination

Epidemiology and Infection

Volumn 144, Issue 6, 2016, Pages 1267-1277

  Mooring, E Q ^a   Bansal, S ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Disease control; epidemiology; influenza (seasonal); mathematical modelling; vaccines

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CONTROLLED STUDY; EPIDEMIC; HEALTH CARE POLICY; HERD IMMUNITY; HUMAN; INFECTION CONTROL; INNATE IMMUNITY; PUBLIC HEALTH; REVACCINATION; RISK REDUCTION; SEASONAL INFLUENZA; SEASONAL VARIATION; VIRUS TRANSMISSION; ADOLESCENT; ADULT; AGED; BRITISH COLUMBIA; CHILD; CITY; IMMUNOLOGY; INFANT; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; SEASON; SECONDARY IMMUNIZATION; THEORETICAL MODEL; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRITISH COLUMBIA; CHILD; CHILD, PRESCHOOL; CITIES; HUMANS; IMMUNITY, HERD; IMMUNIZATION, SECONDARY; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; MODELS, THEORETICAL; PUBLIC HEALTH; SEASONS; YOUNG ADULT;

EID: 84945218295     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815002253     Document Type: Article

References (52)

1. Thompson MG, et al. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. Morbidity and Mortality Weekly Report 2010; 59: 1057-1062.
2. Fiore AE, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Morbidity and Mortality Weekly Report 2010; 59: RR-8.
3. Osterholm MT, et al. Efficacy and effectiveness of influenza vaccines: A systematic review and metaanalysis. Lancet Infectious Diseases 2012; 12: 36-44.
4. Reichert TA, et al. The Japanese experience with vaccinating schoolchildren against influenza. New England Journal of Medicine 2001; 344: 889-896.
5. Simonsen L, et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Archives of Internal Medicine 2005; 165: 265-272.
6. Bodewes R, Kreijtz JHCM, Rimmelzwaan GF. Yearly influenza vaccinations: A double-edged sword? Lancet Infectious Diseases 2009; 9: 784-788.
7. Skowronski DM, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: Four observational studies from Canada. PLoS Medicine 2010; 7: e1000258.
8. Bodewes R, et al. Annual vaccination against influenza virus hampers development of virus-specific CD8+ T cell immunity in children. Journal of Virology 2011; 85: 11995-12000.
9. Bodewes R, et al. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 2012; 30: 7407-7410.
10. Ohmit SE, et al. Influenza vaccine effectiveness in the community and the household. Clinical Infectious Diseases 2013; 56: 1363-1369.
11. McLean HQ, et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clinical Infectious Diseases 2014; 59: 1375-85.
12. Ohmit SE, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clinical Infectious Diseases 2014; 58: 319-27.
13. Ohmit SE, et al. Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. Journal of Infectious Diseases 2015; 211: 1519-28.
14. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. American Journal of Epidemiology 1988; 127: 353-364.
15. Voordouw ACG, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. Journal of the American Medical Association 2004; 292: 2089-2095.
16. Smith DJ, et al. Variable efficacy of repeated annual influenza vaccination. Proceedings of the National Academy of Sciences USA 1999; 96: 14001-14006.
17. Carrat F, et al. Repeated influenza vaccination of healthy children and adults: borrow now, pay later? Epidemiology and Infection 2006; 134: 63-70.
18. Longini IM, Halloran ME. Strategy for distribution of influenza vaccine to high-risk groups and children. American Journal of Epidemiology 2005; 161: 303-306.
19. Bansal S, Pourbohloul B, Meyers LA. A comparative analysis of influenza vaccination programs. PLoS Medicine 2006; 3: e387.
20. Medlock J, Galvani AP. Optimizing influenza vaccine distribution. Science 2009; 325: 1705-1708.
21. Glasser J, et al. Evaluation of targeted influenza vaccination strategies via population modeling. PLoS ONE 2010; 5: e12777.
22. Fung IC-H, Antia R, Handel A. How to minimize the attack rate during multiple influenza outbreaks in a heterogeneous population. PLoS ONE 2012; 7: e36573.
23. Yamin D, et al. An innovative influenza vaccination policy: targeting last season's patients. PLoS Computational Biology 2014; 10: e1003643.
24. Bansal S, Meyers LA. The impact of past epidemics on future disease dynamics. Journal of Theoretical Biology 2012; 309: 176-184.
25. Bansal S, et al. The shifting demographic landscape of pandemic influenza. PLoS ONE 2010; 5: e9360.
26. Lu P-J, et al. Surveillance of influenza vaccination coverage-United States, 2007-08 through 2011-12 influenza seasons. Morbidity and Mortality Weekly Report 2014; 62: SS-4 1-28.
27. Ferrari MJ, et al. Network frailty and the geometry of herd immunity. Proceedings of the Royal Society of London, Series B: Biological Sciences. 2006; 273: 2743-2748.
28. Lloyd-Smith JO, et al. Superspreading and the effect of individual variation on disease emergence. Nature 2005; 438: 355-359.
29. Meyers L, et al. Network theory and SARS: predicting outbreak diversity. Journal of Theoretical Biology 2005; 232: 71-81.
30. Barclay VC, et al. Positive network assortativity of influenza vaccination at a high school: Implications for outbreak risk and herd immunity. PLoS ONE 2014; 9: e87042.
31. O'Malley AJ, et al. Egocentric social network structure, health, and pro-social behaviors in a national panel study of Americans. PLoS ONE 2012; 7: e36250.
32. Xakellis GC. Predictors of influenza immunization in persons over age 65. Journal of the American Board of Family Practice 2005; 18: 426-433.
33. Szilagyi PG, et al. Effect of patient reminder/recall interventions on immunization rates: A review. Journal of the American Medical Association 2000; 284: 1820-1827.
34. Bansal S, Grenfell BT, Meyers LA. When individual behavior matters: homogeneous and network models in epidemiology. Journal of the Royal Society Interface 2007; 4: 879-891.
35. Couch RB, Kasel JA. Immunity to influenza in man. Annual Review of Microbiology 1983; 37: 529-549.
36. Pease C. An evolutionary epidemiological mechanism, with applications to type A influenza. Theoretical Population Biology 1987; 31: 422-452.
37. Finkenstädt B, Morton A, Rand D. Modelling antigenic drift in weekly flu incidence. Statistics in Medicine 2005; 24: 3447-3461.
38. Cowling BJ, et al. Incidence of influenza virus infections in children in Hong Kong in a 3-year randomized placebo-controlled vaccine study, 2009-2012. Clinical Infectious Diseases 2014; 59: 517-524.
39. Belongia EA, et al. Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine 2015; 33: 246-251.
40. Govaert ME, et al. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. Journal of the American Medical Association 1994; 272: 1661-1665.
41. Murasko DM, et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Experimental Gerontology 2002; 37: 427-439.
42. Jefferson T, et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005; 365: 773-780.
43. Jefferson T, et al. Efficacy and effectiveness of influenza vaccines in elderly people: A systematic review. Lancet 2005; 366: 1165-1174.
44. Nichol KL. Efficacy and effectiveness of influenza vaccination. Vaccine 2008; 26S: D17-D22.
45. Ambrose CS, Levin MJ, Belshe RB. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza and Other Respiratory Viruses 2010; 5: 67-75.
46. Jackson LA, et al. Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: A randomized, placebo-controlled trial over two influenza seasons. BMC Infectious Diseases 2010; 10: 71.
47. Centers for Disease Control and Prevention. March flu vaccination coverage United States, 2011-12 influenza season. 2012 (http://www.cdc.gov/flu/pdf/fluvaxview/national-flu-survey-mar2012.pdf).
48. Centers for Disease Control and Prevention. Table: Self-reported influenza vaccination coverage trends 1989-2008 among adults by age group, risk group, race/ethnicity, health-care worker status, and pregnancy status, United States, National Health Interview Survey (NHIS). (http://www.cdc.gov/flu/pdf/professionals/nhis89-08fluvaxtrendtab.pdf). 2012.
49. Centers for Disease Control and Prevention. Estimates of influenza vaccination target population sizes in 2006 and recent vaccine uptake levels. (http://www.cdc.gov/flu/professionals/vaccination/pdf/targetpopchart.pdf). Accessed 8 May 2013.
50. Cox RJ, Brokstady KA, Ograz P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scandinavian Journal of Immunology 2004; 59: 1-15.
51. Gill PW, Murphy AM. Naturally acquired immunity to influenza type A: A clinical and laboratory study. Medical Journal of Australia 1976; 2: 329-333.
52. UddinM, et al. Demographic and socioeconomic determinants of influenza vaccination disparities among university students. Journal of Epidemiology and Community Health 2010; 64: 808-813.